Maciej Kostrubiec
Overview
Explore the profile of Maciej Kostrubiec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
778
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zannad F, Berwanger O, Corda S, Cowie M, Gamra H, Gibson C, et al.
Nat Med
. 2024 Oct;
30(10):2745-2755.
PMID: 39402268
Cardiovascular clinical trials continue to under-represent children, older adults, females and people from ethnic minority groups relative to population disease distribution. Here we describe strategies to foster trial representativeness, with...
2.
Mavromanoli A, Jimenez D, Sanchez O, Sobkowicz B, Vanni S, Kurzyna M, et al.
Thromb Res
. 2023 Oct;
231:29-31.
PMID: 37778058
No abstract available.
3.
Wick K, Aggarwal N, Curley M, Fowler 3rd A, Jaber S, Kostrubiec M, et al.
Lancet Respir Med
. 2022 Sep;
10(9):916-924.
PMID: 36057279
The acute respiratory distress syndrome (ARDS) is a common critical illness syndrome with high morbidity and mortality. There are no proven pharmacological therapies for ARDS. The current definition of ARDS...
4.
Plywaczewska M, Jimenez D, Lankeit M, Pruszczyk P, Kostrubiec M
Dis Markers
. 2021 Dec;
2021:6655958.
PMID: 34925647
Introduction: Risk stratification is mandatory for optimal management of patients with acute pulmonary embolism (APE). Previous studies indicated that renal dysfunction predicts outcome and can improve risk assessment in APE....
5.
Purkayastha P, Iftikhar M, Kostrubiec M
Cureus
. 2021 Oct;
13(9):e17913.
PMID: 34660108
Like many other countries at the moment, the United Kingdom (UK) is currently under national lockdown due to the coronavirus disease 2019 (COVID-19) pandemic. An unfortunate consequence of such social...
6.
Kostrubiec M
JACC Cardiovasc Interv
. 2021 Sep;
14(17):1947-1949.
PMID: 34503746
No abstract available.
7.
Arrigo M, Price S, Baran D, Poss J, Aissaoui N, Bayes-Genis A, et al.
Lancet Respir Med
. 2021 Jul;
9(10):1192-1202.
PMID: 34245691
Acute myocardial infarction complicated by cardiogenic shock (AMICS) is a critical syndrome with a high risk of morbidity and mortality. Current management consists of coronary revascularisation, vasoactive drugs, and circulatory...
8.
Plywaczewska M, Pruszczyk P, Kostrubiec M
Cardiol J
. 2021 Jan;
29(5):858-865.
PMID: 33470418
Cardiovascular circulation and kidney function are closely interrelated. The impairment of renal function is a well-known hazard of increased mortality and morbidity of patients with heart failure or coronary artery...
9.
Pruszczyk P, Kurnicka K, Ciurzynski M, Hobohm L, Thielmann A, Sobkowicz B, et al.
Pol Arch Intern Med
. 2020 Jun;
130(9):741-747.
PMID: 32579314
Introduction: Although the prognostic value of various echocardiographic parameters of right ventricular dysfunction (RVD) was reported in normotensive patients with acute pulmonary embolism (PE), there is no generally accepted definition...
10.
Dzikowska-Diduch O, Kostrubiec M, Kurnicka K, Lichodziejewska B, Pacho S, Miroszewska A, et al.
Thromb Res
. 2019 Dec;
186:30-35.
PMID: 31862573
Introduction: The concept of post Pulmonary Embolism syndrome includes various combinations of functional, haemodynamic or imaging abnormalities in patients after pulmonary embolism (PE). Although residual obstruction of pulmonary vascular bed...